Zurich Cantonal Bank’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $889K | Buy |
+69,324
| New | +$883K | ﹤0.01% | 1497 |
|
|
2025
Q4 | – | Sell |
-53,603
| Closed | -$738K | – | 3192 |
|
|
2025
Q3 | $926K | Buy |
53,603
+18,275
| +52% | +$225K | ﹤0.01% | 1336 |
|
|
2025
Q2 | $331K | Sell |
35,328
-1,467
| -4% | -$12K | ﹤0.01% | 1898 |
|
|
2025
Q1 | $262K | Buy |
36,795
+4,540
| +14% | +$45.9K | ﹤0.01% | 1963 |
|
|
2024
Q4 | $376K | Buy |
32,255
+5,350
| +20% | +$83.5K | ﹤0.01% | 1799 |
|
|
2024
Q3 | $553K | Sell |
26,905
-682
| -2% | -$15.7K | ﹤0.01% | 1502 |
|
|
2024
Q2 | $617K | Buy |
27,587
+4,824
| +21% | +$115K | ﹤0.01% | 1344 |
|
|
2024
Q1 | $626K | Sell |
22,763
-622
| -3% | -$17.3K | ﹤0.01% | 1327 |
|
|
2023
Q4 | $713K | Buy |
23,385
+647
| +3% | +$18.6K | ﹤0.01% | 1261 |
|
|
2023
Q3 | $719K | Buy |
22,738
+2,656
| +13% | +$103K | ﹤0.01% | 1174 |
|
|
2023
Q2 | $819K | Buy |
20,082
+1,933
| +11% | +$78.4K | ﹤0.01% | 1045 |
|
|
2023
Q1 | $676K | Buy |
18,149
+1,329
| +8% | +$52.1K | ﹤0.01% | 1112 |
|
|
2022
Q4 | $587K | Buy |
16,820
+1,043
| +7% | +$49.6K | ﹤0.01% | 1160 |
|
|
2022
Q3 | $883K | Buy |
15,777
+247
| +2% | +$15.3K | 0.01% | 886 |
|
|
2022
Q2 | $804K | Sell |
15,530
-723
| -4% | -$36.7K | ﹤0.01% | 952 |
|
|
2022
Q1 | $1.18M | Buy |
16,253
+174
| +1% | +$14.7K | 0.01% | 870 |
|
|
2021
Q4 | $1.9M | Buy |
16,079
+2,424
| +18% | +$304K | 0.01% | 760 |
|
|
2021
Q3 | $1.83M | Buy |
13,655
+832
| +6% | +$126K | 0.01% | 772 |
|
|
2021
Q2 | $2.08M | Buy |
12,823
+1,283
| +11% | +$99.9K | 0.01% | 719 |
|
|
2021
Q1 | $926K | Buy |
11,540
+5,337
| +86% | +$358K | 0.01% | 908 |
|
|
2020
Q4 | $337K | Buy |
6,203
+778
| +14% | +$28.3K | ﹤0.01% | 1508 |
|
|
2020
Q3 | $108K | Hold |
5,425
| – | – | ﹤0.01% | 1948 |
|
|
2020
Q2 | $114K | Buy |
5,425
+2,299
| +74% | +$39.1K | ﹤0.01% | 1873 |
|
|
2020
Q1 | $38K | Buy |
3,126
+1,430
| +84% | +$19.3K | ﹤0.01% | 2069 |
|
|
2019
Q4 | $25K | Hold |
1,696
| – | – | ﹤0.01% | 2448 |
|
|
2019
Q3 | $23K | Buy |
1,696
+439
| +35% | +$7K | ﹤0.01% | 2411 |
|
|
2019
Q2 | $21K | Hold |
1,257
| – | – | ﹤0.01% | 2454 |
|
|
2019
Q1 | $21K | Sell |
1,257
-4,476
| -78% | -$66.7K | ﹤0.01% | 2401 |
|
|
2018
Q4 | $78K | Hold |
5,733
| – | – | ﹤0.01% | 1752 |
|
|
2018
Q3 | $164K | Hold |
5,733
| – | – | ﹤0.01% | 1426 |
|
|
2018
Q2 | $157K | Buy |
5,733
+4,807
| +519% | +$116K | ﹤0.01% | 1385 |
|
|
2018
Q1 | $20K | Hold |
926
| – | – | ﹤0.01% | 2416 |
|
|
2017
Q4 | $18K | Buy |
+926
| New | +$21.4K | ﹤0.01% | 2430 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
